SORRENTO THERAPEUTICS, INC. Item 8.01. Other Events.
As previously disclosed,
As previously disclosed, on
As previously disclosed, on
On
Cautionary Statement Concerning Forward-Looking Statements
This Current Report on Form 8-K includes certain statements that are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "expect," "should," "would," "plan," "predict," "potential," "seem," "seek," "future," "outlook," and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding the Company's ability to enforce on its arbitration award in the Cynviloq Arbitration. The Company's actual results or outcomes and the timing of certain events may differ significantly from those discussed in any forward-looking statements. These statements are based on various assumptions and on the current expectations of the Company's management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability.
Actual events and circumstances are difficult or impossible to predict and will
differ from assumptions. Many actual events and circumstances are beyond the
control of the Company. These forward-looking statements are subject to a number
of risks and uncertainties, including risks associated with Sorrento's ability
to enforce on its arbitration award in the Cynviloq Arbitration, the
unpredictability of trading markets and whether a market will be established for
the Company's common stock; the potential adverse impact of the Company's
bankruptcy proceedings pursuant to Chapter 11 (the "Chapter 11 Cases") on the
Company's liquidity and results of operations; changes in the Company's ability
to meet its financial obligations during the Chapter 11 process and to maintain
contracts that are critical to its operations; the outcome and timing of the
Chapter 11 process; the effect of the Chapter 11 Cases on the Company's
relationships with vendors, regulatory authorities, employees and other third
parties; possible proceedings that may be brought by third parties in connection
with the Chapter 11 process; the timing or amount of any recovery, if any, to
the Company's stakeholders; any effects of the Chapter 11 Cases on the
enforcement of the arbitration award in the Cynviloq Arbitration; the trading of
the Company's common stock on the Pink Open Market; and those factors discussed
in the Company's Annual Report on Form 10-K for the year ended
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
104 Cover Page Interactive Data File, formatted in Inline Extensible Business
Reporting Language (iXBRL).
© Edgar Online, source
